Search research articles
Contact Us
Filters
Showing results (101-110 of 218) with videos related to
Page
of 22
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 1, 2010
Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk
Daniel C Beachler, Lan L Gellert, Lisa P Jacobson, et al.
Blood
|
September 14, 2012
Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma
Lynn I Levin, Ellen T Chang, Richard F Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2004
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors
Anthony T C Chan, Qian Tao, Keith D Robertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 6, 2009
The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma
Brahim Aissani, Kisani M Ogwaro, Sadeep Shrestha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)
Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 21, 2020
Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection
Seema A Mehta Steinke, Mona Alfares, Alexandra Valsamakis, et al.
Blood Advances
|
September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide
Laura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T<sub>REG</sub>-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
Leena Yoon, Lauren N MacMullen, Leonardo Josué Castro Muñoz, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 26, 2013
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas
Lili Li, Jianming Ying, Xin Tong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2020
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study
Suman Paul, Marianna Zahurak, Leo Luznik, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 218) with videos related to
Sort By:
Page
of 22
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 1, 2010
Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk
Daniel C Beachler, Lan L Gellert, Lisa P Jacobson, et al.
Blood
|
September 14, 2012
Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma
Lynn I Levin, Ellen T Chang, Richard F Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2004
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors
Anthony T C Chan, Qian Tao, Keith D Robertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 6, 2009
The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma
Brahim Aissani, Kisani M Ogwaro, Sadeep Shrestha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)
Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 21, 2020
Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection
Seema A Mehta Steinke, Mona Alfares, Alexandra Valsamakis, et al.
Blood Advances
|
September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide
Laura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T<sub>REG</sub>-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
Leena Yoon, Lauren N MacMullen, Leonardo Josué Castro Muñoz, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 26, 2013
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas
Lili Li, Jianming Ying, Xin Tong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2020
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study
Suman Paul, Marianna Zahurak, Leo Luznik, et al.
Page
of 22